These effects, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the strategy of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Issues. Researchers think that blocking this scavenger https://archimedess735qoq0.bloguerosa.com/profile